Streetbeat News

Equity Actions

PRI

Primerica has announced Tracy Tan as the successor to the current CFO. Tan will assume the role of Executive Vice President, Finance from October 16, 2023, and will become CFO no later than April 1, 2024.

Portfolio Pulse from Benzinga Newsdesk

September 14, 2023 | 8:02 pm

U

Unity Software Inc (NYSE:U) has introduced a controversial fee structure, the Runtime Fee, which charges developers based on the number of installations for games created with the Unity engine once they exceed a specific threshold. This announcement has led to a significant drop in Unity's stock price. It has also been revealed that several high-ranking Unity executives sold substantial amounts of the company's stock in the weeks preceding the fee announcement.

Portfolio Pulse from Franca Quarneti

September 14, 2023 | 7:58 pm

DWAC

Hunter Biden, son of President Joe Biden, has been indicted on federal firearms charges. The charges are related to his possession of a federal firearms license and allegations of dishonesty about his drug addiction. The indictment includes two counts of making false statements and one count of possessing a gun as a drug user. Hunter Biden is also under investigation for his business dealings, with potential additional charges related to tax payments. The news has sparked reactions from various political figures, including former President Donald Trump, who shared his thoughts via his social media company set to merge with Digital World Acquisition Corporation (NASDAQ:DWAC).

Portfolio Pulse from Chris Katje

September 14, 2023 | 7:35 pm

ARM

NVDA

SFTBY

Arm Holdings PLC (ARM) has launched its IPO at a valuation of $54.5 billion, with shares trading at around $60. SoftBank Group Corp (SFTBY), which bought Arm in 2016 for $32 billion, retains 90% of its holdings. SoftBank's founder, Masayoshi Son, emphasized Arm's role in the AI revolution and sees significant AI applications benefiting from Arm and other AI tech players. Arm's designs play a vital role in Nvidia's (NVDA) AI-powered chips.

Portfolio Pulse from AJ Fabino

September 14, 2023 | 7:33 pm

TMUS

A significant investor has taken a bearish stance on T-Mobile US (NASDAQ:TMUS), with 57% of the investors opening trades with bearish expectations. The whales have been targeting a price range from $115.0 to $150.0 for T-Mobile US over the last 3 months. The price of TMUS is up 1.29% at $143.32. Raymond James has maintained their Strong Buy rating on T-Mobile US, with a price target of $172.

Portfolio Pulse from Benzinga Insights

September 14, 2023 | 7:16 pm

SBSW

Sibanye Stillwater is considering a possible restructuring of its South Africa gold operations and has entered Section 189 consultations. This news has led to an increase in the company's share price.

Portfolio Pulse from Benzinga Newsdesk

September 14, 2023 | 6:50 pm

SQ

A significant bearish stance has been taken on Block (NYSE:SQ) as evidenced by unusual options activity. The sentiment among big-money traders is split between 23% bullish and 76% bearish. Whales have been targeting a price range from $45.0 to $85.0 for Block over the last 3 months. The price of SQ is currently down -0.87% at $53.68. Several experts have downgraded their ratings on Block, with price targets ranging from $65 to $90.

Portfolio Pulse from Benzinga Insights

September 14, 2023 | 6:46 pm

BIOL

CMND

FWBI

IBEX

MYTE

PFSW

U.S. stocks traded higher with the Nasdaq Composite gaining more than 100 points. First Wave BioPharma shares spiked 23% after announcing a license agreement for capeserod from Sanofi. PFSweb shares shot up 48% after GXO Logistics announced it will acquire the company. MYT Netherlands Parent B.V. shares gained 13% after reporting Q4 financial results. IBEX Limited shares dropped 25% after reporting worse-than-expected Q4 results and issuing FY24 revenue guidance below estimates. Clearmind Medicine shares were down 57% after announcing pricing of a public offering. BIOLASE shares fell 38% after announcing pricing of a public offering.

Portfolio Pulse from Lisa Levin

September 14, 2023 | 6:30 pm

MRO

Raymond James analyst John Freeman reiterated a Strong Buy rating on Marathon Oil Corp (NYSE:MRO) and raised the price target from $40 to $45. MRO exceeded 2Q estimates due to stronger liquids production and is expected to maintain strong growth due to its aggressive buyback program. The company's untapped potential in Equatorial Guinea and robust FCF estimates for 2024 also contribute to its positive outlook.

Portfolio Pulse from Shivani Kumaresan

September 14, 2023 | 6:19 pm

BMY

Bristol-Myers Squibb & Co (NYSE:BMY) plans to double the number of treatments undergoing clinical trials in the next 18 months, focusing on targeted protein degradation and cell therapies. The company currently has six candidates in various trial phases and intends to advance an additional six in its research pipeline. Bristol-Myers Squibb is also expanding its manufacturing capacity and advancing multiple next-generation assets, including new targets.

Portfolio Pulse from Vandana Singh

September 14, 2023 | 5:53 pm